ACR, Radiation Oncologists to Speak to FDA at Dose Meeting

May 17, 2010 - The radiation oncology community will discuss steps manufacturers of linear accelerators, radiation therapy treatment planning systems and radiation therapy simulators can take to help reduce misadministration and misaligned exposures.

The discussion will take place at a public meeting, "Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures From Therapeutic Radiation," held by the U.S. Food and Drug Administration (FDA), June 9-10, 2010, 8:00 a.m., at the Hilton Hotel Washington, D.C., North in Gaithersburg, Md.

Albert L. Blumberg, M.D., FACR, chair of the American College of Radiology (ACR) Commission on Radiation Oncology, James Hevezi, Ph.D., FACR, chair of the ACR Medical Physics Commission, and Indra J. Das, Ph.D., FACR, ACR radiation oncology program surveyor, will speak on behalf of the ACR at the meeting.

Several ACR members and staff are expected to take part in the meeting. The College will keep members informed of major developments regarding this very important issue.

For more information: http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm21…